Suppression of acute experimental allergic encephalomyelitis in lewis rats with a mycophenolic acid derivative

Tohoku Journal of Experimental Medicine

Volumn 182, Issue 3, 1997, Pages 217-229

  Mizobuchi, Masahiro ^a   Iwasaki, Yuzo ^b   Sako, Kazuya ^a   Kaneko, Yutaro ^c  

^a Nakamura Memorial Hospital   (Japan)

^b MIYAGI NATIONAL HOSPITAL   (Japan)

^c AJINOMOTO CO INC   (Japan)

Author keywords

Experimental allergic encephalomyelitis; Immunosuppressant; Multiple selerosis; Mycophenolic acid; T cell subset

Indexed keywords

[N (4 CARBOXYPHENYLCARBAMOYL)]MYCOPHENOLIC ACID ETHYL ESTER; MYCOPHENOLIC ACID; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; RAT;

ADMINISTRATION, ORAL; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MYCOPHENOLIC ACID; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; SPINAL CORD;

EID: 0030846825     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.182.217     Document Type: Article

References (21)

1. Allison, A.C., Kowalski, W.J., Muller, C.J., Waters, R.V. & Eugui, E.M. (1993) Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Transplant. Proc., 25, Suppl. 2, 67-70.
2. Arnason, B.G.W. (1983) Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol. Clin., 1, 765-782.
3. Carr, S.F., Papp, E., Wu, J.C. & Natsumeda, Y. (1993) Characterization of human type I and type II IMP dehydrogenases. J. Biol. Chem., 268, 27286-27290.
4. Clatch, R.J., Miller, S.D., Metzner, R., Dal Canto, M.C. & Lipton, H.L. (1990) Monocyte/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology, 176, 244-254.
5. Cohen, J.A., Essayan, D.M., Zweiman, B. & Lisak, R.P. (1987) Limiting dilution analysis of frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell. Immunol., 108, 203-213.
6. Ensley, R.D., Bristow, M.R., Olsen, S.L., Taylor, D.O., Hammond, E.H., O'Connell, J.B., Dunn, D., Osburn, L., Jones, K.W., Kauffman, R.S., Gay, W.A. & Renlund, D. G. (1993) The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation, 56, 75-82.
7. Ericsson, P.O., Linden, O., Dohlsten, M., Sjogren, H.O. & Hedlund, G. (1991) Functions of rat CD4+ T cell subsets defined by CD45RB; CD45RB-cells have a much stronger response to recall antigens, whereas polyclonally activated cells of both subsets are equally efficient producers of INF in the presence of exogeous IL-2. Cell. Immunol., 132, 391-399.
8. Eugui, E.M., Mirkovich, A. & Allison, A.C. (1991a) Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand. J. Immunol., 33, 175-183.
9. Eugui, E.M., Almquist, S.J., Muller, C.D. & Allison, A.C. (1991b) Lymphocyteselective cytostatic and immunosuppressive effects of mycophenolic acid in vitro; role of deoxyguanosine nucleotide depletion. Scand. J. Immunol., 33, 161-173.
10. Goldblum, R. (1993) Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin. Exp. Rheumatol., 11, Suppl. 8, S117-119.
11. Konno, Y., Natsumeda, Y., Nagai, M., Yamaji, Y., Ohno, S., Suzuki, K. & Weber, G. (1991) Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. J. Biol. Chem., 266, 506-509.
12. Matzuzawa, Y. & Nakase, T. (1984) Metabolic fate of ethyl O-[N-(p-carboxyphenyl-carbamoyl]-mycophenolate (CAM), a new antitumor agent, in experimental animals. J. Pharm. Dyn., 7, 776-783.
13. Mckhann, G.M. (1990) Therapeutic trials for multiple sclerosis. Ann. Neurol., 27, 589-590.
14. Mitsui, A. & Suzuki, S. (1969) Immunosuppressive effect of mycophenolic acid. J. Antibiotics., 12, 358-363.
15. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
16. Nagai, M., Natsumeda, Y. & Weber, G. (1992) Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Cancer Res., 52, 258-261.
17. Ohsugi, Y., Suzuki, S. & Takagaki, Y. (1976) Antitumor and immunosuppressive effects of mycophenolic acid derivatives. Cancer Res., 36, 2923-2927.
18. Sako, K., Iwasaki, Y., Ohara, Y., Tsunoda, I. & Okumura, K. (1993) Anti-very late antigen-4 antibody suppresses acute active experimental allergic encephalomyelitis in Lewis rats. J. Neuropathol. Exper. Neurol., 52, 310.
19. Sollinger, H.W., Deierhoi, M.H., Belzer, F.O., Diethelm, A.G.& Kauffman, R.S. (1992) RS-61443-A phase I clinical trial and pilot rescue study. Tranplantation, 53, 428-432.
20. Takazawa, K., Hosoda, Y., Bashuda, H., Yagita, H., Okumura, K. & Kaneko, Y. (1995) CAM-a novel immunosuppressive agent. Transplantation, 59, 1723-1727.
21. Waters, R.V., Webster, D. & Allison, A.C. (1993) Mycophenolic acid and some antioxidants induce differentiation of monocytic lineage cells and augment production of the IL-1 receptor antagonist. Ann. N.Y. Acad. Sci., 696, 185-196.